>peptide 1 (40 aa)
LYALVRSPTTIPWSHTKATVIPFHLFTISIFFLLFFSEYL*
>peptide 2 (72 aa)
MRAKVLVEFLAYRFEVLLSMVSLTQASTLLLLMLNRLNKWLITYFFSCTIIFSSKFFLYNAYCSYHRLLGWI*
>peptide 3 (33 aa)
MFNFYETYQYWNLFYLVMILLVIVLIRNLVYEE*
>peptide 4 (75 aa)
MLGSGTNLVTTVIGFGMSATFIVFVCTRIICGRLRGGVESRMMYEIESRIDMEQVSLAVPFSFLCPFFPFTVFCL*
>peptide 5 (88 aa)
MPKCGHTFHLSCIDIWLRKQSTCPVCRLPLKNSSETKHVRPVTFTMSQSLDESHTSDRNDDIERYVEPTPTAASNSLQPTSGEQEARQ*
>peptide 6 (37 aa)
SLCSCTFPHHHPLESHQSHCDSIPSLHNFYFFSSLFL*
>peptide 7 (55 aa)
MILRDMLNLHLLQPVTLYNQLQENKKQGNDLRELKGLFCSKREECRISASIEECF*
>peptide 8 (48 aa)
MAFIFTWWCKYVSFCSICGPRFWWNFLHTDLKFFCLWYRLLKQAHCSC*
>peptide 9 (35 aa)
MAEETIHLSSMPSAVEKLFRNETCETCDIYHEPIP*
>peptide 10 (29 aa)
MFLDPPNIIVDHKRILCLICNLVYVILHC*
>CNT0002951
CTCTCTATGCTCTTGTACGTTCCCCCACCACCATCCCTTGGAGTCACACCAAAGCCACTGTGATTCCATTCCATCTCTTCACAATTTCTATTTTTTTTCT
TCTCTTTTTCTCTGAATACCTCTAAAGTTTCCATTTTTCTGACATGGGTATCTCTTATTTTCTCTGTTTCTCTTAGTTTCAATCTTCTCTTCTTGTCTCT
TTGGACTTGTCACGTGTGGGGTGCCATCATGTGTTTGTGTTGAAGAATCTGTGAAGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTTTCTATATGCTGT
GGTGCTGCTTCTGTTGCTACTTGTGCTTATAGCTTTTGGGGTTTGTGTGTTGTGGATTGGATTTTGGGTTGGAGATGTTGGGTTCAGGTACCAATTTGGT
GACCACGGTCATTGGGTTTGGGATGAGTGCCACTTTCATTGTGTTTGTGTGCACCAGAATCATTTGTGGGAGGCTAAGAGGGGGTGTTGAATCTCGGATG
ATGTACGAGATTGAATCAAGAATTGATATGGAACAGGTAAGTTTGGCTGTGCCTTTTTCCTTCCTTTGCCCCTTTTTCCCGTTTACTGTTTTTTGCTTGT
GAACGTGGCTAGATTTTGAGTGCTATGTTCAATTTTTATGAAACTTATCAATATTGGAATCTATTTTATTTGGTCATGATTCTTTTGGTTATTGTTCTGA
TCCGGAACTTAGTGTATGAGGAATGAGGATAGCTGCAATTTTTTGCTGTTTTTTGTAACTTTTGATTCTGATGCAAATGCTGCATTCTGTTTCCAAAAGT
AAACCTGCGACTTGGCTGTAAACTTTCAATAAGATGTAGAGAATTGGGTATTTGTATCAATGAATGTGTATACTGCCCCTTAATATTGATTGTCATTTGT
CTTGGTTAGATACTAAGATGTACAGAAATGTTCTAATTGTACTGTAGTGGAGACTTTTCCATTGTTAATAACAACAATGAAGCCTTATCCCACAAGATGA
GTTCAACTACATAGATCGCACAATGACATTTGGCTTGGTTAAAGACCAAATCTTCACAGATAGCAACATTATATTCGGGTGCTGATGCAGTGGCTCTAAC
TCATTTGACACAGTACTGTAGCCATATACAACACTTTACTTCTGGATAACAACCTAGCATTAGCAAAAATCTGTTGTGTGTGATCCATGTCCCGTATATC
GACAAGTTTTATGTTAACTGCCTAGAGCCTGATACAATCCTCCTCCTTTACTTGGGCTTGGGACTGGCTATGAAACTATAGGCGGTGTTACTTTTTCATT
GTTAATGTTTCATATAATTTCAAGCTCATGAATTTGAATGTTTCTTGACCCTCCAAATATAATAGTTGATCACAAGAGAATACTTTGTCTAATTTGTAAT
TTAGTTTATGTCATTCTGCACTGTTAAGGTTGGTTGCTTTAGATTTTAATTTTTCATTGTTTACTGATAGCCAGAACATCATGTTAATGACCCTGAATCC
GATCCTGTTCTTCTTGATGCAATCCCTACTTTGAAGTTCAACCAAGAGGCTTTCAGTTCCCTTGAACACACACAGTGTGTAATATGTTTGGCAGATTACA
GAGAAAGAGAAGTATTGCGCATCATGCCCAAATGTGGCCACACTTTTCATCTTTCTTGCATTGATATATGGCTGAGGAAACAATCCACCTGTCCAGTATG
CCGTCTGCCGTTGAAAAACTCTTCCGAAACGAAACATGTGAGACCTGTGACATTTACCATGAGCCAATCCCTTGACGAGTCTCACACATCAGACAGAAAC
GATGATATTGAGAGATATGTTGAACCTACACCTACTGCAGCCAGTAACTCTTTACAACCAACTTCAGGAGAACAAGAAGCAAGGCAATGATCTTAGAGAA
CTAAAGGGGTTGTTCTGCTCAAAAAGAGAAGAATGTAGAATTTCTGCTTCTATAGAGGAATGCTTCTAATTATAGATTGGATTCAAATTCTTTGTCTGTA
ATATGGCCTTCATATTCACTTGGTGGTGTAAATATGTTTCCTTTTGTAGCATATGCGGGCCAAGGTTTTGGTGGAATTTCTTGCATACCGATTTGAAGTT
CTTTTGTCTATGGTATCGCTTACTCAAGCAAGCACACTGCTCTTGTTAATGCTTAACAGATTAAACAAATGGTTGATTACATATTTTTTTTCTTGTACAA
TTATTTTTAGTAGCAAATTTTTTCTATATAATGCTTATTGTTCTTATCATAGGTTATTAGGATGGATCTAGAAAATTTGGATAGTGGG
| Potential function | Interacting transcript | Gene description | Transcript biotype | lncRNA id | Alignment score (LAST) | Alignment length | Transcript region involved in interaction | Genomic orientation of interacting RNAs |
|---|---|---|---|---|---|---|---|---|
| GLYMA13G07450.2 | Uncharacterized protein | protein coding | CNT0002951 | 108 | 84 | CDS | Trans | |
| GLYMA13G28480.2 | Uncharacterized protein | protein coding | CNT0002951 | 89 | 66 | CDS_UTR | Trans | |
| GLYMA16G01410.2 | Uncharacterized protein | protein coding | CNT0002951 | 99 | 70 | UTR3 | Trans | |
| GLYMA16G01410.3 | Uncharacterized protein | protein coding | CNT0002951 | 99 | 70 | UTR3 | Trans |